NEW YORK, April 03, 2018 /PRNewswire/ --
WallStEquities.com strives to bring the best free research to the investmentcommunity. Today we are offering reports on WBA, ABC, CAH, and MCK which can be accessed for free by signing up to www.wallstequities.com/registration. On Monday, benchmark US indices were in bearish colors as the NASDAQ Composite closed the trading
Walgreens Boots Alliance
Deerfield, Illinois-based Walgreens Boots Alliance Inc.'s stock finished Monday's session 3.62% lower at $63.10. A total volume of 7.68 million shares was traded, which was above its three months average volume of 5.84 million shares. The stock is trading below its 50-day moving average by 10.85%. Furthermore, shares of the Company, which operates as a pharmacy-led health and wellbeing company, have a Relative Strength Index (RSI) of 31.84.
On March 23rd, 2018, research firm Pivotal Research Group reiterated its 'Hold' rating on the Company's stock with a decrease of the target price from $73 a share to $69 a share. Get the full research report on WBA for free by clicking below at: www.wallstequities.com/registration/?symbol=WBA
Shares in Chesterbrook, Pennsylvania headquartered AmerisourceBergen Corp. ended at $82.67, down 4.11% from the last trading session. The stock recorded a trading volume of 1.95 million shares. The stock is trading below its 50-day moving average by 13.74%. Moreover, shares of AmerisourceBergen, which sources and distributes pharmaceutical products in the US and internationally, have an RSI of 30.79.
On March 08th, 2018, research firm Barclays initiated an 'Equal Weight' rating on the Company's stock, with a target price of $104 per share. ABC's complimentary research coverage is a few simple steps away at: www.wallstequities.com/registration/?symbol=ABC
Dublin, Ohio headquartered Cardinal Health Inc.'s stock ended yesterday's session 2.66% lower at $61.01 with a total trading volume of 2.91 million shares. The stock is trading below its 50-day moving average by 11.46%. Additionally, shares of Cardinal Health, which operates as an integrated healthcare services and products company worldwide, have an RSI of 29.81.
On April 02nd, 2018, research firm Argus upgraded the Company's stock rating from 'Hold' to 'Buy'. Are you already registered with Wall St. Equities? Do so now for free, and get the report on CAH at: www.wallstequities.com/registration/?symbol=CAH
On Monday, shares in San Francisco, California headquartered McKesson Corp. recorded a trading volume of 1.92 million shares, which was above their three months average volume of 1.79 million shares. The stock finished the day 0.75% lower at $139.81. The stock is trading below its 50-day moving average by 9.49%. Furthermore, shares of McKesson, which provides pharmaceuticals and medical supplies in the US and internationally, have an RSI of 30.45.
On March 08th, 2018, research firm Barclays initiated an 'Equal Weight' rating on the Company's stock, with a target price of $165 per share. Aspiring Member, please take a moment to register below for your free research report on MCK at: www.wallstequities.com/registration/?symbol=MCK
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: email@example.com Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/this-mornings-technical-outlook-on-services-stocks----walgreens-boots-alliance-amerisourcebergen-cardinal-health-and-mckesson-300623255.html
SOURCE Wall St. Equities
Subscribe to our Free Newsletters!
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...
Graviola's health benefits range from curing headaches to fighting cancer. Read on to know more ...
Gene therapy is a specialized procedure where genetic material is introduced into the cells of a ...View All